To access this element change to forms mode OFF
Grant Award View - GA271257
Novel approaches to the treatment and monitoring of patients with...
GA ID:
GA271257
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
1-Sep-2022
Publish Date:
31-Oct-2022
Category:
Medical Research
Grant Term:
1-Jan-2023 to 31-Dec-2027
Value (AUD):
$974,844.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 21/22 1.1 Health and Medical Research
Grant Program:
Investigator Grants
Grant Activity:
Novel approaches to the treatment and monitoring of patients with incurable haematological cancers
Purpose:
This project will focus on 2 largely incurable forms of blood cancer; T cell lymphoma (TCL) and acute myeloid leukemia (AML). We will join international collaborators contributing to large databases to examine the causes and predictors of outcome of TCL. I will undertake completely novel clinical trials using non-chemotherapy therapies which will include the scale-up in our laboratory of genetically engineered human immune cells called CART cells specifically designed for treating TCL and AML.
GO ID:
GO Title:
Investigator Grants 2022
Internal Reference ID:
2022/GNT2017646
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Melbourne
Recipient ABN:
84 002 705 224
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA